These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 6701538)

  • 1. Biochemistry of human plasminogen.
    Castellino FJ
    Semin Thromb Hemost; 1984 Jan; 10(1):18-23. PubMed ID: 6701538
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of anisoylated Lys-plasminogen streptokinase activator complex to cells in culture.
    Vasudevan J; Humphries JE; Gonias SL
    Thromb Haemost; 1993 Apr; 69(4):370-4. PubMed ID: 8388580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modification of the streptokinase gene to study the interaction of streptokinase with plasminogen.
    Lizano S; Johnston KH
    Dev Biol Stand; 1995; 85():195-8. PubMed ID: 8586175
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptokinase and urokinase activation of human, chimpanzee and baboon plasminogen.
    McKee PA; Lemmon WB; Hampton JW
    Thromb Diath Haemorrh; 1971 Dec; 26(3):512-22. PubMed ID: 5004225
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptokinase contains two independent plasminogen-binding sites.
    Nihalani D; Sahni G
    Biochem Biophys Res Commun; 1995 Dec; 217(3):1245-54. PubMed ID: 8554583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of plasminogen activation by a plasmin substrate containing a lysyl residue.
    Machovich R; Owen WG
    Thromb Haemost; 1993 Nov; 70(5):864-6. PubMed ID: 8128447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
    Nihalani D; Raghava GP; Sahni G
    Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of rabbit plasminogen to streptokinase in circulating blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1973; 11(3):235-43. PubMed ID: 4778383
    [No Abstract]   [Full Text] [Related]  

  • 12. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biology of human plasminogen. II. Metabolism in physiological and some pathological conditions in man.
    Collen D; Verstraete M
    Thromb Diath Haemorrh; 1975 Nov; 34(2):403-8. PubMed ID: 1105875
    [No Abstract]   [Full Text] [Related]  

  • 14. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
    Thorsen S
    Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and susceptibility to thrombolysis of pathological human arterial thrombi.
    Brommer EJ; Potter van Loon BJ; Rijken DC; van Bockel JH
    Ann N Y Acad Sci; 1992 Dec; 667():283-5. PubMed ID: 1309047
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct activation of human plasminogen by streptokinase.
    Summaria L; Hsieh B; Groskopf WR; Robbins KC
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):737-43. PubMed ID: 5773661
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.
    Lampsas S; Xenou M; Oikonomou E; Pantelidis P; Lysandrou A; Sarantos S; Goliopoulou A; Kalogeras K; Tsigkou V; Kalpis A; Paschou SA; Theofilis P; Vavuranakis M; Tousoulis D; Siasos G
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulated
    Nohawica M; Nowak-Terpilowska A; Adamska K; Wyganowska-Swiatkowska M
    Postepy Dermatol Alergol; 2022 Oct; 39(5):944-952. PubMed ID: 36457693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus co-opts a conformational lock in human plasminogen to facilitate streptokinase cleavage and bacterial virulence.
    Ayinuola YA; Brito-Robinson T; Ayinuola O; Beck JE; Cruz-Topete D; Lee SW; Ploplis VA; Castellino FJ
    J Biol Chem; 2021; 296():100099. PubMed ID: 33208461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.